Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Balloul

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 31, 2004
Gene-based vaccines and immunotherapeuticsMargaret Liu, Bruce Acres, Jean-Marc Balloul, et al.
Molecular Therapy. Oncology|July 13, 2026
Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic virusesClara Fauveau, Emily Lawendy, Jules Deforges, et al.
Cancer Research|October 19, 2005
Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicityBruce Acres, Murielle Gantzer, Christelle Remy, et al.
Vaccine|June 3, 2017
Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17Emma Petiot, Anaïs Proust, Aurélien Traversier, et al.
Viral Immunology|December 27, 2007
Specific tumor cell targeting by a recombinant MVA expressing a functional single chain antibody on the surface of intracellular mature virus (IMV) particlesStéphane Paul, Michel Geist, Karine Dott, et al.
Frontiers in Oncology|August 2, 2024
3D bioprinted CRC model brings to light the replication necessity of an oncolytic vaccinia virus encoding <i>FCU1</i> gene to exert an efficient anti-tumoral activityChristophe A Marquette, Emma Petiot, Anita Spindler, et al.
Frontiers in Immunology|May 3, 2024
Patient-derived tumoroids and proteomic signatures: tools for early drug discoveryHélène Lê, Jules Deforges, Pasquale Cutolo, et al.
Cancers|November 27, 2025
Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic DeliveryColin McGuckin, Nico Forraz, Clément Milet, et al.
Cancer Gene Therapy|April 19, 2002
Tumor gene therapy by MVA-mediated expression of T-cell-stimulating antibodiesStephane Paul, Etienne Regulier, Ronald Rooke, et al.
BMC Veterinary Research|August 27, 2020
Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogsJérémy Béguin, Virginie Nourtier, Murielle Gantzer, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Proceedings of the National Academy of Sciences of the United States of America|August 31, 2004
Gene-based vaccines and immunotherapeuticsMargaret Liu, Bruce Acres, Jean-Marc Balloul, et al.
Molecular Therapy. Oncology|July 13, 2026
Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic virusesClara Fauveau, Emily Lawendy, Jules Deforges, et al.
Cancer Research|October 19, 2005
Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicityBruce Acres, Murielle Gantzer, Christelle Remy, et al.
Vaccine|June 3, 2017
Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17Emma Petiot, Anaïs Proust, Aurélien Traversier, et al.
Viral Immunology|December 27, 2007
Specific tumor cell targeting by a recombinant MVA expressing a functional single chain antibody on the surface of intracellular mature virus (IMV) particlesStéphane Paul, Michel Geist, Karine Dott, et al.
Frontiers in Oncology|August 2, 2024
3D bioprinted CRC model brings to light the replication necessity of an oncolytic vaccinia virus encoding <i>FCU1</i> gene to exert an efficient anti-tumoral activityChristophe A Marquette, Emma Petiot, Anita Spindler, et al.
Frontiers in Immunology|May 3, 2024
Patient-derived tumoroids and proteomic signatures: tools for early drug discoveryHélène Lê, Jules Deforges, Pasquale Cutolo, et al.
Cancers|November 27, 2025
Colorectal Cancer Hepatic Metastasis Modeling by Advanced 3D Bioprinting Allows Demonstration of Oncolytic Viral Chemotherapeutic DeliveryColin McGuckin, Nico Forraz, Clément Milet, et al.
Cancer Gene Therapy|April 19, 2002
Tumor gene therapy by MVA-mediated expression of T-cell-stimulating antibodiesStephane Paul, Etienne Regulier, Ronald Rooke, et al.
BMC Veterinary Research|August 27, 2020
Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogsJérémy Béguin, Virginie Nourtier, Murielle Gantzer, et al.
Pageof 2